EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ondine Biomedical's enterprise value is $43.63 Mil.
Ondine Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1.46 Mil. Therefore, Ondine Biomedical's EV-to-Revenue for today is 29.84.
The historical rank and industry rank for Ondine Biomedical's EV-to-Revenue or its related term are showing as below:
OBIMF'
s EV-to-Revenue Range Over the Past 10 Years
Min: -0.72 Med: 20.05 Max: 126.67
Current: 29.84
During the past 13 years, the highest EV-to-Revenue of Ondine Biomedical was 126.67. The lowest was -0.72. And the median was 20.05.
OBIMF's EV-to-Revenue is ranked worse than 74.62% of 997
companies
in the Biotechnology industry
Industry Median: 7.28
vs OBIMF: 29.84
The historical data trend for Ondine Biomedical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ondine Biomedical's EV-to-Revenue
For the Biotechnology subindustry, Ondine Biomedical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ondine Biomedical's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ondine Biomedical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Ondine Biomedical's EV-to-Revenue falls into.
Ondine Biomedical's current Enterprise Value is $43.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ondine Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ondine Biomedical's share price for today is $0.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ondine Biomedical EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Ondine Biomedical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OBIMF has been successfully added to your 